GlassScriptPhysician profile
Linda Luu
NPI 1932957354
$3,701.79
in general payments reported to CMS, 2019-2025
9 companies · $3,296 in 2025
The $3,296 reported for 2025 was more than what 98% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $406 · 2025: $3,296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,882 · Food and Beverage: $1,820.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,881.80 |
| Food and Beverage | $1,819.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $2,240.17 | 2025 | Cvi Contact Lens |
| Bausch & Lomb Americas INC. | $524.42 | 2024-2025 | Infuse, Miebo |
| Mallinckrodt Hospital Products INC. | $201.21 | 2025 | Acthar |
| Biotissue Holdings INC. | $198.74 | 2025 | |
| Tarsus Pharmaceuticals, INC. | $177.38 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $136.21 | 2024-2025 | Acrysof Iq Panoptix Uv Iol, Precision 1 |
| Dompe US, INC. | $101.38 | 2025 | Oxervate |
| Rxsight INC | $93.75 | 2024 | Rxsight Contact Lens, Rxsight Injector Cartridge, Light Adjustable Lens (Lal) |
| Oyster Point Pharma, INC. | $28.53 | 2024 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linda Luu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.